Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : CFZ E-Wiggle Workspace -- Ignore unavailable to you. Want to Upgrade?

To: skinowski who wrote (38373)	3/16/2021 7:22:38 PM
From: robert b furman	Read Replies (1) \| Respond to of 41518

Hi ski, Brooks acquired Genewhiz two years ago, a genome sequencing global leader. Brooks Automation Buys GENEWIZ, Expands Genomics FootprintBrooks Automation's (BRKS) acquisition of GENEWIZ Group for roughly $450 million is the company's largest in the life sciences space. More More content below More content below BRKS -1.52% 7731.T -0.52% Brooks Automation BRKS recently announced that it is acquiring New Jersey-based genomics company, GENEWIZ Group for roughly $450 million. This is the company’s largest acquisition to-date in the life sciences space. The transaction is expected to close by the end of 2018. GENEWIZ offers gene sequencing and synthesis services to more than 4,000 institutional customers worldwide. The company’s primary end-markets are pharmaceutical and academic institutions. The acquisition significantly expands Brooks Automation’s footprint in the life sciences market, primarily in the Genomics services. GENEWIZ has significant growth prospects in next-gen and Sanger sequencing market. The company’s addressable market size is expected to see a CAGR of 17% between 2018 and 2023. Brooks Automation expects the acquisition to contribute revenues of $140 million in fiscal 2019. Non-GAAP gross margins are expected to be almost 50%. GENEWIZ is immediately accretive to non-GAAP earnings. Brooks Automation shares jumped 5.1% to close at $33.79 on Sep 26. The stock has returned 41.7% year to date, while the Zacks Electronics Manufacturing Machinery industry has lost 8.2%. I suspect Arks massive buying power has driven Brks ascending price. I'm at a loss of what sanger sequencing is or genome sequencing is? Bob Bob